Sandrine Baghdoyan
Corbeil-essonnes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Generation and characterization of three human induced pluripotent stem cell lines from patients with Duchenne muscular dystrophy.
Journal: Stem cell research
Published: April 02, 2026
Generation of two iPSC lines each carrying a stop codon mutation, c.366T > A (p.Y122X) and c.1657C > T (p.R553X), in the CFTR gene from the parental line PCIi033-A using CRISPR/Cas9.
Journal: Stem cell research
Published: March 18, 2026
Generation of two iPSC lines carrying two cystic fibrosis rare intronic mutations c.1585-1G>A and c.1680-886A>G in the CFTR gene of the parental line PCIi033-A using CRISPR/Cas tools.
Journal: Stem cell research
Published: March 18, 2026
Integrative analysis of drug-gene signatures in human pluripotent stem cells reveals prazosin as a novel SQSTM1 regulator for ALS therapeutics.
Journal: Stem cell reports
Published: November 25, 2025
CRISPR-Cas9 genome editing in the parental iPSC line PCIi033-A to introduce the homozygous mutation p.F508del (c.1521_1523del) in the CFTR gene.
Journal: Stem cell research
Published: October 07, 2025
Pluripotent Stem Cells in Disease Modeling and Drug Discovery for Myotonic Dystrophy Type 1.
Journal: Cells
Published: January 10, 2023
Pharmacological research and pluripotent stem cells: from the innovative experimental paradigm to the successful clinical trial
Journal: Medecine sciences : M/S
Published: January 24, 2019
Improved mobility with metformin in patients with myotonic dystrophy type 1: a randomized controlled trial.
Journal: Brain : a journal of neurology
Published: April 11, 2018
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin.
Journal: Molecular therapy. Nucleic acids
Published: May 15, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026